Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

DARLYN KELLER

UEI: FEDLZMMLC3M4

DARLYN KELLER is a federal contractor, registered under UEI FEDLZMMLC3M4. It has been awarded $48,000 across 1 federal contract. Primary work spans Other Personal Care Services. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

FEDLZMMLC3M4

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$48.0K100%
Awards by NAICS
812199 - Other Personal Care Services$48.0K100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in DARLYN KELLER's top NAICS codes and agencies

NAICS: 513210
New
Federal
Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscription
Solicitation # 7571TE26Q00153
The U.S. Food and Drug Administration, through the Department of Health and Human Services, intends to sole-source a firm fixed-price contract to Simulations Plus Inc. for twenty GastroPlus and five DDDPlus software licenses, used for physiologically based pharmacokinetic and physiologically based biopharmaceutics modeling in support of generic drug research. The contract spans a base year from September 1, 2026, to August 31, 2027, with up to three one-year option periods extending through August 31, 2030. Performance will occur at the FDA’s White Oak campus in Silver Spring, Maryland. The acquisition is conducted under RFO 12, allowing for non-competitive procurement of commercial products, and no set-aside applies. Responses are due by August 14, 2026, and any interested party may submit a capability statement to demonstrate their ability to supply the exact software licenses as the original equipment manufacturer or authorized reseller, which the government will review solely to determine whether competitive procurement is warranted. The contract requires the vendor to provide standard individual licenses, with no auto-renewals permitted unless explicitly authorized. Acceptance of deliverables will be conducted by the Contracting Officer’s Representative within 30 working days of delivery, verifying software functionality, compatibility with FDA systems, and compliance with technical requirements. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and all invoices must include detailed supporting documentation for labor, materials, and costs. The government retains the right to reject nonconforming deliveries and will not pay for services that fail to meet agreed standards. Clauses from the FAR and HHSAR govern payment, representation, whistleblower rights, anti-lobbying, accessibility, and dispute resolution, with federal regulations taking precedence over any vendor terms. The Contracting Officer and Contract Specialist are the primary points of contact, and all vendors must be actively registered in SAM at the time of submission.
Department Of Health And Human Services

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541715
New
Federal
Antioxidant Therapy for Smith-Lemli-Opitz Syndrone
Solicitation # NICHD-08610
The contract pertains to the development and implementation of antioxidant therapy for Smith-Lemli-Opitz Syndrome, a rare genetic disorder characterized by multiple congenital anomalies and metabolic dysfunction. The solicitation, issued under NICHD-08610 by the Department of Health and Human Services through its National Institutes of Health, invites proposals aimed at advancing targeted antioxidant interventions to mitigate the pathological effects of the condition. The opportunity was posted on August 3, 2026, with responses due by August 18, 2026, at 2:00 PM Eastern Time. The work is expected to be performed in Bethesda, Maryland, consistent with the research infrastructure of the NIH campus. All proposals must be submitted through the SAM.gov portal and should address scientific rigor, feasibility, and potential clinical impact. The primary point of contact for inquiries is Niamh Cawley, with Chung Huang as the secondary contact, both reachable via NIH email addresses. The contracting activity falls under the Department of Health and Human Services with no set-aside provisions specified, and no NAICS code is assigned, indicating flexibility in contractor categorization. Interested parties should ensure adherence to deadlines and submission requirements outlined on the official UI link linked in the posting.
Department Of Health And Human Services

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 562111
New
Federal
Notice of Intent / Sole Source Solid Waste
Solicitation # 75H71026Q00223
The Navajo Area Indian Health Service, Shiprock Service Unit, intends to award a sole-source, firm-fixed-price contract to Navajo Sanitation for solid waste collection services at the Dzilth-Na-O-Dith-Hle Health Center in Bloomfield, New Mexico, with performance beginning September 1, 2026, and ending August 31, 2027. The procurement is justified under unusual and compelling urgency due to the contractor’s unique, uninterrupted history of providing essential waste management services at the facility, ensuring continuity of operations critical to patient care. The North American Industry Classification System code is 562111, with a small business size standard of $47 million in annual revenue. No competitive solicitation will be issued unless a respondent submits clear and convincing evidence that competition would benefit the government. Responses must be submitted in writing as a capability statement by August 17, 2026, at 10:00 a.m. MST, and must not include proprietary, classified, confidential, or sensitive information. The government is not obligated to respond to or acknowledge submissions, and failure to receive affirmative responses will result in contract award without further notice. All information provided may be used in future solicitations if competition is pursued, and any resulting solicitation will be publicly announced on SAM.gov. The point of contact for inquiries is Ken Parrish, Purchasing Agent, reachable at ken.parrish@ihs.gov.
Department Of Health And Human Services

POSTED

6 days ago

DEADLINE

in 13 days
View Details
NAICS: 812199
SLED
Massage Therapy Minor Use Permit Type B, PLN26-00069
Solicitation # PLN26-00069
The applicant is seeking approval for a Minor Use Permit to operate a new appointment-only massage therapy business within an existing 2,359-square-foot building located at 4130 Grass Valley Highway Suite B in Auburn, Placer County, California. The project is categorized as a personal service use and is designated under NAICS code 812199, with the permitting authority being the Placer County Community Development Resource Agency. The Entitlement/Action Date for the permit is June 18, 2026, and the request has been posted on June 22, 2026. The project has been determined to be categorically exempt from environmental review under Section 15305 of the California Environmental Quality Act Guidelines and Placer County Code Section 18.36.070, Class 5, which pertains to minor alterations in land use limitations. The Zoning Administrator is required to affirm this exempt status before the permit can be granted. The Assessor’s Parcel Number for the site is 076-061-039-000, and the primary point of contact for the process is Claudia Garcia, Technician at the agency, reachable via phone or email. No procurement, pricing, delivery, or contract administration terms are applicable, as this is a land-use entitlement and zoning approval process, not a federal or commercial procurement contract. The solicitation number for the permit is PLN26-00069.
Placer County Community Development Resource Agency

POSTED

about 1 month ago

DEADLINE

N/A
View Details
NAICS: 812199
SLED
CUP26-0003 ("Fountain of Youth Skin and Body care")
Solicitation # CUP26-0003
The City of Glendora has issued a conditional use permit application, CUP26-0003, for Fountain of Youth Skin and Body Care, seeking approval to operate massage therapy services alongside its existing beauty spa operations under the provisions of Glendora Municipal Code Section 5.10. This permit authorizes the expansion of services to include professional massage therapy, subject to compliance with local zoning regulations and conditions set forth by the city's planning department. The application is tied to a single location in Glendora, California, with a ZIP code of 91741, and is being reviewed under the city's land use and conditional use permitting process. The primary point of contact for the city is Earvin Adolfo, the Planning Technician, reachable via email and phone, while Claudia Ponce de Leon, the Certified Massage Therapist and owner of the business, serves as the secondary contact. The permit is forecasted for issuance with a posted date of June 12, 2026, and all relevant documentation and project details are accessible through the California Environmental Quality Act online portal. The permit does not involve a set-aside program, nor is it associated with a NAICS code or federal procurement mechanism, as it is strictly a municipal land use approval process aimed at ensuring compatibility with neighborhood standards and regulatory compliance.
City of Glendora

POSTED

about 2 months ago

DEADLINE

N/A
View Details
NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.
Department of Health and Human Services

POSTED

2 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.
Department of Health and Human Services

POSTED

2 months ago

DEADLINE

in 8 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.
Department of Health and Human Services

POSTED

2 months ago

DEADLINE

in 8 months
View Details
NAICS: 812199
SLED
2507-03 (AUP25-012)
Solicitation # 2507-03 (AUP25-012)
The City of Long Beach has issued an Administrative Use Permit (AUP25-012) to authorize the establishment of a tattoo parlor within an existing 891-square-foot commercial space located at 1232-1234 Belmont Avenue in the Mixed-Use 3 (MU-3-A) zoning district. This use change is subject to compliance with local zoning regulations, particularly the requirement that the facility be situated more than 700 feet from any public or private primary or secondary school. The project qualifies for a categorical exemption under the California Environmental Quality Act (CEQA) as Class 1 (15301), which applies to minor interior alterations to existing facilities without expansion of use or structure, thereby eliminating the need for an environmental impact report. The permit application was reviewed and approved administratively by the Community Development Department, with no new construction or physical modifications to the building planned. Martin Rodriguez of MRD Studio is identified as the project owner and applicant, while Gopi Shah, Planner I in the City of Long Beach’s Community Development Department, serves as the primary point of contact for administrative inquiries. The permit is not a federal contract and does not incorporate any Federal Acquisition Regulation (FAR) clauses, nor does it include pricing, payment terms, invoicing protocols, or delivery schedules typically associated with procurement agreements. No accounting codes, unique entity identifiers, socioeconomic certifications, or federal contract types are applicable or present. All administrative processes, including environmental clearance and zoning compliance, are governed by local ordinances and CEQA guidelines. The place of performance is clearly defined as 1232-1234 Belmont Avenue, Long Beach, California 90804, and acceptance of the permit is contingent upon adherence to the conditions outlined in the administrative approval process by the City of Long Beach.
City of Long Beach

POSTED

9 months ago

DEADLINE

N/A
View Details